Results
90
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
90 companies
Takeda Pharmaceutical
Market Cap: JP¥6.7t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,288.00
7D
-1.4%
1Y
6.5%
Nippon Shinyaku
Market Cap: JP¥229.1b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,400.00
7D
-6.7%
1Y
8.6%
Daiichi Sankyo Company
Market Cap: JP¥6.2t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,308.00
7D
-5.9%
1Y
-39.3%
Astellas Pharma
Market Cap: JP¥2.4t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,351.50
7D
-2.7%
1Y
-11.6%
Sumitomo Pharma
Market Cap: JP¥389.7b
Engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally.
4506
JP¥981.00
7D
-7.3%
1Y
178.7%
Eisai
Market Cap: JP¥1.1t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥3,944.00
7D
-2.7%
1Y
-38.0%
Shionogi
Market Cap: JP¥2.1t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
4507
JP¥2,502.00
7D
0.6%
1Y
24.9%
Tsumura
Market Cap: JP¥250.2b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥3,349.00
7D
-0.7%
1Y
-18.8%
Heartseed
Market Cap: JP¥73.0b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥3,235.00
7D
-13.7%
1Y
n/a
Otsuka Holdings
Market Cap: JP¥3.7t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥7,007.00
7D
-3.4%
1Y
9.7%
NANO MRNALtd
Market Cap: JP¥10.7b
Researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan.
4571
JP¥151.00
7D
14.4%
1Y
-12.2%
PhoenixBio
Market Cap: JP¥1.5b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥380.00
7D
0.3%
1Y
-21.6%
BrightPath Biotherapeutics
Market Cap: JP¥4.3b
Engages in the development of cancer immunotherapy drugs in Japan.
4594
JP¥48.00
7D
20.0%
1Y
-12.7%
K PharmaInc
Market Cap: JP¥8.8b
Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.
4896
JP¥760.00
7D
-5.9%
1Y
10.3%
Pharma Foods International
Market Cap: JP¥25.5b
Engages in the development and sale of functional food ingredients in Japan.
2929
JP¥882.00
7D
-2.6%
1Y
-11.6%
Sawai Group Holdings
Market Cap: JP¥215.3b
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
4887
JP¥1,864.50
7D
2.4%
1Y
-2.4%
Carna Biosciences
Market Cap: JP¥6.0b
A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.
4572
JP¥312.00
7D
-10.9%
1Y
-17.9%
Linical
Market Cap: JP¥7.3b
Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.
2183
JP¥321.00
7D
-0.3%
1Y
-20.1%
Takara Bio
Market Cap: JP¥94.3b
Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.
4974
JP¥783.00
7D
0%
1Y
-24.9%
Solasia Pharma K.K
Market Cap: JP¥7.0b
Engages in the development and marketing of oncology drugs in Japan and other Asian countries.
4597
JP¥32.00
7D
6.7%
1Y
18.5%
Kidswell Bio
Market Cap: JP¥16.2b
Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.
4584
JP¥370.00
7D
22.1%
1Y
174.1%
SymBio Pharmaceuticals
Market Cap: JP¥8.6b
Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.
4582
JP¥176.00
7D
3.5%
1Y
9.3%
CellSource
Market Cap: JP¥13.8b
Engages in the regenerative medicine-related businesses in Japan.
4880
JP¥699.00
7D
-3.2%
1Y
-43.2%
Ribomic
Market Cap: JP¥4.5b
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan.
4591
JP¥102.00
7D
12.1%
1Y
7.4%
TMS
Market Cap: JP¥6.8b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥168.00
7D
-2.9%
1Y
-28.2%
Kissei Pharmaceutical
Market Cap: JP¥170.3b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,110.00
7D
-1.7%
1Y
29.4%
Chugai Pharmaceutical
Market Cap: JP¥11.8t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,189.00
7D
-3.6%
1Y
39.4%
Human Metabolome Technologies
Market Cap: JP¥4.7b
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.
6090
JP¥807.00
7D
-0.5%
1Y
24.2%
Fuso Pharmaceutical IndustriesLtd
Market Cap: JP¥18.0b
Manufactures and sells pharmaceuticals and medical equipment in Japan.
4538
JP¥2,102.00
7D
-1.2%
1Y
-10.9%
CanBas
Market Cap: JP¥18.5b
A clinical stage biopharmaceutical company, develops therapeutics for cancer patients.
4575
JP¥966.00
7D
3.3%
1Y
105.5%
D. Western Therapeutics Institute
Market Cap: JP¥5.4b
A biotechnology company, focuses on discovery and development of various drugs.
4576
JP¥120.00
7D
-4.8%
1Y
26.3%
Kringle Pharma
Market Cap: JP¥6.1b
Engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines.
4884
JP¥894.00
7D
-12.4%
1Y
12.3%
Shin Nippon Biomedical Laboratories
Market Cap: JP¥57.1b
A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.
2395
JP¥1,372.00
7D
2.5%
1Y
-0.8%
RaQualia Pharma
Market Cap: JP¥13.8b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥566.00
7D
-9.6%
1Y
-9.6%
DNA Chip Research
Market Cap: JP¥7.3b
Develops DNA microarrays in Japan.
2397
JP¥1,085.00
7D
-1.3%
1Y
-13.3%
JCR Pharmaceuticals
Market Cap: JP¥66.0b
Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.
4552
JP¥542.00
7D
-4.9%
1Y
-7.0%